PURE Bioscience, Inc. (PURE)

Import this data to Google Sheets with:

=jivedata("PURE","financials")

Full statements spill as a table. For one cell: =jivedata("PURE","Revenue") or =jivedata("PURE","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

PURE Bioscience, Inc.

PURE • CIK 0001006028

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$1,877	$1,963	$2,202	$2,422
Cost of Goods and Services Sold	$906	$811	$899	$997
Gross Profit	$971	$1,152	$1,303	$1,425
Operating Income (Loss)	$-3,943	$-3,191	$-2,272	$-1,916
Net Income (Loss) Attributable to Parent	$-3,961	$-3,350	$-2,399	$-2,205
Weighted Average Number of Shares Outstanding, Basic	111,404,418	111,856,473	111,862,884	111,549,458
Selling, General and Administrative Expense	$4,302	$3,981	$3,259	$3,029
Research and Development Expense	$297	$302	$316	$312
Impairment of Long-Lived Assets to be Disposed of	$315	$60	$60	$60
Operating Expenses	$4,914	$4,343	$3,575	$3,341
InterestExpenseNonoperating	—	$155	$299	$390
Other Nonoperating Income (Expense)	$-4	$-4	$172	$101
Nonoperating Income (Expense)	$-18	$-159	$-127	$-289

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Property, Plant and Equipment, Net	$221	$13	$11	$9
Assets	$1,825	$818	$1,058	$1,558
Liabilities	$1,553	$3,682	$6,174	$7,397
Cash and Cash Equivalents, at Carrying Value	$1,095	$349	$334	$983
Accounts Receivable, after Allowance for Credit Loss, Current	$285	$298	$474	$242
Inventory, Net	$88	$56	$141	$232
Restricted Cash, Current	—	—	$75	$75
Prepaid Expense, Current	$61	$27	$23	$17
Assets, Current	$1,604	$805	$1,047	$1,549
Accounts Payable, Current	$422	$601	$784	$719
Accrued Liabilities, Current	$110	$132	$154	$181
Liabilities, Current	$532	$733	$938	$3,654
Common Stock, Value, Issued	$1,119	$1,119	$1,119	$1,301
Additional Paid in Capital	$132,398	$132,612	$132,759	$133,727
Retained Earnings (Accumulated Deficit)	$-133,245	$-136,595	$-138,994	$-140,867
Stockholders' Equity Attributable to Parent	$272	$-2,864	$-5,116	$-5,839
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	150,000,000	200,000,000	200,000,000	200,000,000
Common Stock, Shares, Issued	111,856,473	111,856,473	111,886,473	130,017,569
Inventory Valuation Reserves	$259	$238	$212	$147
Impairment of Long-Lived Assets to be Disposed of	$315	$60	$60	$60
Depreciation	$117	$148	$2	$2

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-3,961	$-3,350	$-2,399	$-2,205
Net Cash Provided by (Used in) Operating Activities	$-3,278	$-2,531	$-2,015	$-1,780
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-2,296	$-746	$-15	$443
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$1,170	$424	$409	$497
Share-based Payment Arrangement, Noncash Expense	$324	$214	$147	$177
Proceeds from Related Party Debt	$1,015	—	$2,000	$1,220
Impairment of Long-Lived Assets to be Disposed of	$315	$60	$60	$60
Net Cash Provided by (Used in) Financing Activities	$1,015	$1,785	$2,000	$2,223
Depreciation, Depletion and Amortization, Nonproduction	$117	$148	$2	$3
Cash and Cash Equivalents, at Carrying Value	$1,095	$349	$334	$422
Restricted Cash	$75	$75	$75	$75
Income Taxes Paid, Net	$5	$5	$3	$3
Increase (Decrease) in Accounts Receivable	$84	$13	$176	$-45
Increase (Decrease) in Inventories	$-57	$-32	$85	$101
Increase (Decrease) in Prepaid Expense	$43	$-34	$-4	$4
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$-43	$201	$205	$-72
Increase (Decrease) in Interest Payable, Net	$6	$143	$287	$378

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("PURE","financials")

Full statements spill as a table. For one cell: =jivedata("PURE","Revenue") or =jivedata("PURE","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.